Title : Future of organoids engineering: biomaterials, mechanobiology, personalized therapeutics
Abstract:
Organoid engineering has emerged as one of the most promising frontiers in biomedical engineering, regenerative medicine, and precision healthcare. These three-dimensional (3D) in vitro tissue models faithfully recapitulate key structural and functional characteristics of native human organs, providing transformative platforms for disease modeling, drug discovery, and personalized therapeutic development. By bridging the gap between conventional two-dimensional cell cultures and in vivo biological systems, organoids are reshaping the landscape of translational biomedical research.
This presentation explores recent advances in organoid engineering through the integration of intelligent biomaterials, mechanobiology, stem cell technologies, organoids-on-a-chip, and artificial intelligence (AI). Special emphasis will be placed on how responsive biomaterials and mechanical microenvironments regulate cellular behavior, tissue morphogenesis, and organoid maturation. Furthermore, the session highlights the growing role of AI and Generative AI in predictive modeling, automated optimization of culture conditions, bio-fabrication, and data-driven decision-making to enhance reproducibility and accelerate personalized medicine.
Current challenges including scalability, biological variability, standardization, and regulatory acceptance will also be discussed alongside emerging solutions involving smart biomaterials, microfluidic systems, and computational modeling. Finally, the presentation outlines future research directions toward AI-enabled bioengineering platforms, human-on-chip technologies, and precision regenerative medicine, illustrating how interdisciplinary convergence between engineering, biology, and computational sciences is poised to revolutionize next-generation healthcare.
